Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vaxcyte Inc
5VACurrent price
103 EUR
0 EUR (0.00%)
Last closed
116.23 USD
Company
vaxcyte.com
ISIN
US92243G1085
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
13 600 486 400 USD
Yield for 12 month
+118.70 %
1Y
3Y
5Y
10Y
15Y
5VA
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
137.86 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-10 171 000 USD
Last Year
-9 196 000 USD
Current Quarter
-3 478 000 USD
Last Quarter
-3 091 000 USD
Key Figures 5VA
1 year
3 years
5 years
10 years
EBITDA
-573 110 976 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.1 %
PEG Ratio
–
Return On Equity TTM
-29.08 %
Wall Street Target Price
137.86 USD
Revenue TTM
–
Book Value
17.96 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-22 995 000 USD
Earnings per share
-4.69 USD
Diluted Eps TTM
-4.69 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 5VA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 5VA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 5VA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-14.4283
Price Book MRQ
6.8434
Financials 5VA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 5VA
For 52 weeks
44.2 USD
119.27 USD
50 Day MA
81.74 USD
Shares Short Prior Month
11 500 169
200 Day MA
70.14 USD
Short Ratio
15.19
Shares Short
11 238 839
Short Percent
11.61 %
BeatStart